The long should still be held because the core thesis—BASF can remain resilient through a mixed macro backdrop—was reinforced by Q1 figures showing solid EBITDA and positive earnings surprises. Price has pulled back from peak progress, but it remains above entry, above the ratcheted stop, and above key daily trend measures, so this looks more like consolidation below resistance than thesis failure.
The original long thesis remains intact: BASF's Q1 2026 EBITDA of €2.4 billion demonstrates sustained pricing power and operational resilience despite geopolitical headwinds. Technically, price remains above key support at €52.31 and within a high-volume node zone, preserving the risk/reward structure. The 1.67:1 reward-to-risk ratio remains favorable with a clear path to €57.77.
The original thesis is still valid, and the position should be held due to the company's resilience amid the Middle East conflict and its strong market position. The recent earnings report and cross-asset checks support this thesis, indicating that the company's diversified product portfolio and strong market position will continue to drive growth and validate the premium.
No model argued for EXIT.
The long should still be held because the core thesis—BASF can remain resilient through a mixed macro backdrop—was reinforced by Q1 figures showing solid EBITDA and positive earnings surprises. Price has pulled back from peak progress, but it remains above entry, above the ratcheted stop, and above key daily trend measures, so this looks more like consolidation below resistance than thesis failure.
The long should still be held because the core thesis—BASF can remain resilient through a mixed macro backdrop—was reinforced by Q1 figures showing solid EBITDA and positive earnings surprises. Price has pulled back from peak progress, but it remains above entry, above the ratcheted stop, and above key daily trend measures, so this looks more like consolidation below resistance than thesis failure.
▼ Click to expandThe case for exiting would be that the trade is running out of time while short-term momentum has deteriorated into nearby resistance and a high-impact ECB event could trigger a bearish break. If BAS loses the €52.31 support area and cannot reclaim momentum quickly, the path to €57.77 within the remaining horizon becomes unrealistic and preserving gains would take priority.
▼ Click to expandThe original long thesis remains intact: BASF's Q1 2026 EBITDA of €2.4 billion demonstrates sustained pricing power and operational resilience despite geopolitical headwinds. Technically, price remains above key support at €52.31 and within a high-volume node zone, preserving the risk/reward structure. The 1.67:1 reward-to-risk ratio remains favorable with a clear path to €57.77.
The original long thesis remains intact: BASF's Q1 2026 EBITDA of €2.4 billion demonstrates sustained pricing power and operational resilience despite geopolitical headwinds. Technically, price remains above key support at €52.31 and within a high-volume node zone, preserving the risk/reward structure. The 1.67:1 reward-to-risk ratio remains favorable with a clear path to €57.77.
▼ Click to expandThe baseline bias has shifted negative, and momentum indicators like RSI and MACD are trending downward across multiple timeframes. The divergence with DBC suggests BAS may be decoupling from broader commodity strength, raising concerns about sector-specific weakness. Additionally, the upcoming ECB rate decision introduces macro risk that could pressure export-oriented European equities.
▼ Click to expandThe original thesis is still valid, and the position should be held due to the company's resilience amid the Middle East conflict and its strong market position. The recent earnings report and cross-asset checks support this thesis, indicating that the company's diversified product portfolio and strong market position will continue to drive growth and validate the premium.
The original thesis is still valid, and the position should be held due to the company's resilience amid the Middle East conflict and its strong market position. The recent earnings report and cross-asset checks support this thesis, indicating that the company's diversified product portfolio and strong market position will continue to drive growth and validate the premium.
▼ Click to expandThe position should be closed if the Middle East conflict escalates, leading to a significant increase in energy costs and a decrease in demand for BASF's products. Additionally, if the technical indicators turn bearish or the cross-asset checks contradict the BAS move, it may be necessary to reconsider the position and potentially exit.
▼ Click to expandIntraday discovery triggered reanalysis on BAS. Verdict: HOLD (0/3 EXIT). Conviction: 54.